Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.3M Sell
103,282
-18,281
-15% -$6.26M 0.1% 145
2026
Q1
$42.9M Buy
121,563
+26,474
+28% +$9.44M 0.13% 120
2025
Q4
$31.1M Buy
95,089
+2,422
+3% +$768K 0.19% 102
2025
Q3
$27.7M Sell
92,667
-2,320
-2% -$673K 0.18% 108
2025
Q2
$27.6M Buy
94,987
+4,199
+5% +$1.19M 0.2% 99
2025
Q1
$27.8M Buy
90,788
+1,581
+2% +$467K 0.23% 89
2024
Q4
$23.3M Buy
89,207
+346
+0.4% +$103K 0.19% 102
2024
Q3
$28.4M Buy
88,861
+2,174
+3% +$711K 0.23% 84
2024
Q2
$27M Buy
86,687
+666
+0.8% +$196K 0.24% 85
2024
Q1
$25.4M Buy
+86,021
New +$25.2M 0.19% 98

Other funds holding AMGN

TD Waterhouse Canada's AMGN Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $6.26M and leaving 103,282 shares worth $37.3M. The position accounts for 0.1% of the portfolio, ranked #145.

TD Waterhouse Canada first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $42.9M in Q1 2026. 1,223 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • TD Waterhouse Canada held 103,282 shares of Amgen worth $37.3M as of Q2 2026.
  • TD Waterhouse Canada sold 18,281 Amgen shares in Q2 2026, an estimated $6.26M.
  • Amgen made up 0.1% of TD Waterhouse Canada's portfolio in Q2 2026, its #145 holding.
  • TD Waterhouse Canada first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • TD Waterhouse Canada's Amgen position peaked at $42.9M in Q1 2026.
  • 1,223 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.